ES2010775A6 - Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos. - Google Patents
Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos.Info
- Publication number
- ES2010775A6 ES2010775A6 ES8802434A ES8802434A ES2010775A6 ES 2010775 A6 ES2010775 A6 ES 2010775A6 ES 8802434 A ES8802434 A ES 8802434A ES 8802434 A ES8802434 A ES 8802434A ES 2010775 A6 ES2010775 A6 ES 2010775A6
- Authority
- ES
- Spain
- Prior art keywords
- phosphate derivatives
- epipodophyllotoxin glucoside
- epipodophyllotoxin
- glucoside
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Cable Accessories (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS FOSFATADOS DE 4''-DESMETILEPIPODOFILOTOXIN GLUCOSIDOS, DE FORMULA (V), DONDE R6 ES H, R1 ES ACIDO C1-10, ALQUENILO C2-10, CICLOALQUILO C5-6, 2-FURILO, 2-TIENILO, ARILO C6-10, ARALQUILO C7-14, ARALQUILO C8-14, DONDE LOS ANILLOS AROMATICOS PUEDEN ESTAR OPCIONALMENTE SUSTITUIDOS O R1 Y R6 Y EL CARBONO AL QUE ESTAN ENLAZADOS FORMAN UN GRUPO CICLOALQUILO C5-6; X ES O O S; R7 Y R8 SON H, ALQUILO C1-5, CICLOALQUILO C3-6, ARILO C6-10, ARALQUILO C7-14, OPCIONALMENTE SUSTITUIDOS. EL PROCEDIMIENTO COMPRENDE LA REACCION DE UN COMPUESTO (IX) CON P(X)CL3 PARA FORMAR UN INTERMEDIO (VIII) QUE PUEDE SER: A) HIDROLIZADO PARA FORMAR UN COMPUESTO (V) DONDE R7 Y R8 SON H; O B) COMBINADO CON AL MENOS UN EQUIVALENTE DE R7OH Y R8OH. OPCIONALMENTE EL COMPUESTO (IX) PUEDE SER PROTEGIDO EN SU GRUPO FOSFATO. LOS COMPUESTOS DE FORMULA (V) SON AGENTES ANTITUMORALES ADECUADOS PARA EL TRATAMIENTO DE DIVERSOS TIPOS DE CANCER, LEUCEMIA NO LINFOCITICA Y ENFERMEDAD DE HODKIN. ADEMAS, SUS SALES FARMACEUTICAS SON MAS SOLUBLES EN AGUA QUE LAS DE OTROS GLUCOSIDOS SIMILARES CONOCIDOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8149387A | 1987-08-04 | 1987-08-04 | |
US07/199,731 US4904768A (en) | 1987-08-04 | 1988-05-27 | Epipodophyllotoxin glucoside 4'-phosphate derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2010775A6 true ES2010775A6 (es) | 1989-12-01 |
Family
ID=26765636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES8802434A Expired ES2010775A6 (es) | 1987-08-04 | 1988-08-03 | Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos. |
Country Status (34)
Country | Link |
---|---|
US (3) | US4904768A (es) |
JP (1) | JPH0699465B2 (es) |
KR (1) | KR900006230B1 (es) |
CN (1) | CN1027169C (es) |
AT (1) | AT398974B (es) |
BE (1) | BE1002982A4 (es) |
CA (1) | CA1310637C (es) |
CH (1) | CH676716A5 (es) |
CY (1) | CY1625A (es) |
CZ (1) | CZ286893B6 (es) |
DD (2) | DD274423A5 (es) |
DE (1) | DE3826562A1 (es) |
DK (2) | DK169344B1 (es) |
ES (1) | ES2010775A6 (es) |
FI (1) | FI87790C (es) |
FR (1) | FR2622193B1 (es) |
GB (1) | GB2207674B (es) |
GR (1) | GR1000490B (es) |
HK (1) | HK6392A (es) |
HU (3) | HU202547B (es) |
IE (1) | IE61040B1 (es) |
IL (1) | IL87290A (es) |
IT (1) | IT1226825B (es) |
LU (2) | LU87290A1 (es) |
MX (1) | MX173843B (es) |
MY (1) | MY104321A (es) |
NL (2) | NL192683C (es) |
NO (4) | NO170284C (es) |
NZ (1) | NZ225615A (es) |
PT (1) | PT88186B (es) |
SE (1) | SE502214C2 (es) |
SG (1) | SG101291G (es) |
SK (1) | SK279325B6 (es) |
YU (3) | YU143688A (es) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5191071A (en) * | 1987-08-21 | 1993-03-02 | Novo Nordisk A/S | Monoesters of glycosides and a process for enzymatic preparation thereof |
US4965348A (en) * | 1989-05-19 | 1990-10-23 | Bristol-Myers Company | Dimeric epipodophyllotoxin glucoside derivatives |
US5036055A (en) * | 1989-06-07 | 1991-07-30 | Bristol-Myers Company | Acylated derivatives of etoposide |
US5066645A (en) * | 1989-09-01 | 1991-11-19 | Bristol-Myers Company | Epipodophyllotoxin altroside derivatives |
US6610299B1 (en) | 1989-10-19 | 2003-08-26 | Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US7241595B2 (en) | 1989-10-20 | 2007-07-10 | Sanofi-Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US6475486B1 (en) | 1990-10-18 | 2002-11-05 | Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US5552154A (en) * | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
US5034380A (en) * | 1989-11-20 | 1991-07-23 | Bristol-Myers Squibb Company | Alkoxymethylidene epipodophyllotoxin glucosides |
US5081234A (en) * | 1990-04-30 | 1992-01-14 | Bristol-Myers Squibb Co. | 4'-demethylepipodophyllotoxin glycosides |
US4997931A (en) * | 1990-06-11 | 1991-03-05 | Bristol-Myers Squibb Company | Epipodophyllotoxin glycosides |
TW260671B (es) * | 1991-04-29 | 1995-10-21 | Bristol Myers Squibb Co | |
IT1250692B (it) * | 1991-07-23 | 1995-04-21 | Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi. | |
US5648474A (en) * | 1991-10-08 | 1997-07-15 | Bristol-Myers Squibb | Crystalline etoposide 4'-phosphate diethanolate |
JPH07632B2 (ja) * | 1991-12-23 | 1995-01-11 | ブリストル−マイヤーズ スクイブ カンパニー | エトポシド4’−ホスフェート二ナトリウム塩の安定な六水和物 |
US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
JP3061476B2 (ja) * | 1992-04-24 | 2000-07-10 | 日本化薬株式会社 | エトポシド燐酸エステルの製造法 |
US5459248A (en) * | 1993-11-04 | 1995-10-17 | Bristol-Myers Squibb Company | Process of preparing etoposide phosphate and etoposide |
FR2725990B1 (fr) * | 1994-10-21 | 1997-01-10 | Pf Medicament | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux |
EP0835303A4 (en) * | 1995-06-07 | 2000-09-13 | Univ Jefferson | ANTIFUNGAL AGENTS AND THEIR IDENTIFICATION AND UTILIZATION METHODS |
DK0907379T3 (da) * | 1996-04-01 | 2004-08-16 | Epix Medical Inc | Bioaktiveret diagnostisk billeddannelseskontrastmiddel |
US6207673B1 (en) | 1997-03-12 | 2001-03-27 | The University Of North Carolina At Chapel Hill | Covalent conjugates of topoisomerase I and topoisomerase II inhibitors |
WO1999032499A1 (en) * | 1997-12-23 | 1999-07-01 | Korea Research Institute Of Chemical Technology | 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES |
EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
US6624317B1 (en) | 2000-09-25 | 2003-09-23 | The University Of North Carolina At Chapel Hill | Taxoid conjugates as antimitotic and antitumor agents |
US6506739B1 (en) | 2001-05-01 | 2003-01-14 | Telik, Inc. | Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents |
WO2003035661A1 (en) * | 2001-10-26 | 2003-05-01 | Centre National De La Recherche Scientifique | Derivatives of etoposide and analogs, and pharmaceutical compositions containing them |
ES2358730T3 (es) | 2002-07-15 | 2011-05-13 | Board Of Regents, The University Of Texas System | Anticuerpos seleccionados y péptidos de duramicina que se enlazan a fosfolípidos aniónicos y aminofosfolípidos y sus usos en el tratamiento de infecciones virales y del cáncer. |
ATE512674T1 (de) * | 2003-01-06 | 2011-07-15 | Angiochem Inc | Angiopep-1, verwandte verbindungen, und deren verwnedungen |
CN100334090C (zh) * | 2005-02-02 | 2007-08-29 | 南京医科大学 | 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用 |
US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
ES2383901T5 (es) * | 2005-02-18 | 2015-02-25 | Angiochem Inc. | Polipéptidos de aprotinina para transportar un compuesto a través de la barrera sangre-cerebro |
EP2233156B1 (en) | 2005-07-15 | 2013-05-01 | Angiochem Inc. | Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
CN100410266C (zh) * | 2006-01-11 | 2008-08-13 | 重庆华邦制药股份有限公司 | 鬼臼毒素磷酸酯衍生物的合成方法 |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
PE20070978A1 (es) * | 2006-02-14 | 2007-11-15 | Novartis Ag | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks) |
AR060358A1 (es) * | 2006-04-06 | 2008-06-11 | Novartis Vaccines & Diagnostic | Quinazolinas para la inhibicion de pdk 1 |
GB0625283D0 (en) * | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
WO2009036106A1 (en) * | 2007-09-13 | 2009-03-19 | Bristol-Myers Squibb Company | Cytotoxic xanthone compounds |
ES2572356T3 (es) | 2007-11-09 | 2016-05-31 | Peregrine Pharmaceuticals Inc | Composiciones de anticuerpos dirigidos contra VEGF y procedimientos |
CA2710122A1 (en) | 2007-12-20 | 2009-07-02 | Novartis Ag | Thiazole derivatives used as pi 3 kinase inhibitors |
ES2721148T3 (es) * | 2008-04-18 | 2019-07-29 | Angiochem Inc | Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso |
BRPI0920209A2 (pt) | 2008-10-15 | 2015-12-22 | Angiochem Inc | conjugados de agonistas de glp-1 e usos dos mesmos |
CN102245636A (zh) | 2008-10-15 | 2011-11-16 | 安吉奥开米公司 | 用于药物递送的依托泊苷和多柔比星结合物 |
AU2009322043A1 (en) * | 2008-12-05 | 2011-07-07 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
AU2009327267A1 (en) | 2008-12-17 | 2011-07-14 | Angiochem, Inc. | Membrane type-1 matrix metalloprotein inhibitors and uses thereof |
EP2421562B1 (en) | 2009-04-20 | 2019-03-13 | Angiochem Inc. | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
CN102596993A (zh) | 2009-07-02 | 2012-07-18 | 安吉奥开米公司 | 多聚体肽结合物以及其应用 |
BR112012019635A2 (pt) | 2010-02-22 | 2016-05-03 | Hoffmann La Roche | compostos inibidores de pirido[3,2-d] pirimidina pi3k delta e métodos de uso |
US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
AR082418A1 (es) | 2010-08-02 | 2012-12-05 | Novartis Ag | Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico |
ES2611885T3 (es) | 2011-01-31 | 2017-05-11 | Novartis Ag | Derivados heterocíclicos novedosos |
US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
PL2771342T3 (pl) | 2011-10-28 | 2016-11-30 | Nowe pochodne puryny i ich zastosowanie w leczeniu chorób | |
EP2788003A4 (en) * | 2011-12-09 | 2015-05-27 | Demerx Inc | PHOSPHATESTER OF NORIBOGAIN |
SG10201608469RA (en) | 2012-05-16 | 2016-11-29 | Novartis Ag | Dosage regimen for a pi-3 kinase inhibitor |
CA2896133A1 (en) | 2012-12-20 | 2014-06-26 | Demerx, Inc. | Substituted noribogaine |
CN105979947A (zh) | 2013-12-06 | 2016-09-28 | 诺华股份有限公司 | α-同工型选择性磷脂酰肌醇3-激酶抑制剂的剂量方案 |
CA2989400A1 (en) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Ang1005 for the treatment of leptomeningeal carcinomatosis |
EP3370719A1 (en) | 2015-11-02 | 2018-09-12 | Novartis AG | Dosage regimen for a phosphatidylinositol 3-kinase inhibitor |
WO2018060833A1 (en) | 2016-09-27 | 2018-04-05 | Novartis Ag | Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib |
KR102378151B1 (ko) | 2020-05-11 | 2022-03-24 | 주식회사 제이앤씨사이언스 | 베타-아포피크로포도필린의 신규한 유도체 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1171314A (fr) * | 1955-05-13 | 1959-01-23 | Sandoz Ag | Produits de condensation de glucosides avec des composés carbonyliques et leur préparation |
NL6613143A (es) * | 1965-09-21 | 1967-03-22 | ||
CH464957A (de) * | 1965-12-14 | 1968-11-15 | Sandoz Ag | Verfahren zur Herstellung eines neuen Glucosids |
CH481097A (de) * | 1966-12-13 | 1969-11-15 | Sandoz Ag | Verfahren zur Herstellung eines neuen Glucosids |
CH514578A (de) * | 1968-02-27 | 1971-10-31 | Sandoz Ag | Verfahren zur Herstellung von Glucosiden |
CH543502A (de) * | 1970-11-20 | 1973-10-31 | Sandoz Ag | Verfahren zur Herstellung neuer Glucoside |
GB1395820A (en) * | 1971-06-05 | 1975-05-29 | Villax I | Preparation of 21-inorganic esters of corticosteroids and salts thereof |
CH589668A5 (en) * | 1973-06-07 | 1977-07-15 | Sandoz Ag | Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde |
FR2397425A1 (fr) * | 1977-07-11 | 1979-02-09 | Rhone Poulenc Ind | Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent |
EP0111058B1 (en) * | 1982-11-26 | 1987-11-04 | Nippon Kayaku Kabushiki Kaisha | Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof |
US4567253A (en) * | 1984-02-03 | 1986-01-28 | Tony Durst | 2-Substituted derivatives of podophyllotoxin and etoposide |
JPS60208910A (ja) * | 1984-03-31 | 1985-10-21 | Green Cross Corp:The | 水難溶性薬物・リン脂質複合体の製造方法 |
JPS60246393A (ja) * | 1984-05-22 | 1985-12-06 | Nippon Kayaku Co Ltd | エトポシドの新規製造法 |
US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
IL77334A (en) * | 1985-12-16 | 1991-04-15 | Univ Bar Ilan | Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor |
US4916217A (en) * | 1987-01-08 | 1990-04-10 | Bristol-Myers Company | Phosphorus containing derivatives of epipodophyllotoxin |
JPS63192793A (ja) * | 1987-02-06 | 1988-08-10 | Nippon Kayaku Co Ltd | 4′−デメチル−エピポドフイロトキシン誘導体の新規エステル |
US4874851A (en) * | 1987-07-01 | 1989-10-17 | Bristol-Meyers Company | 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives |
-
1988
- 1988-05-27 US US07/199,731 patent/US4904768A/en not_active Ceased
- 1988-07-21 MY MYPI88000819A patent/MY104321A/en unknown
- 1988-07-22 LU LU87290A patent/LU87290A1/fr active Protection Beyond IP Right Term
- 1988-07-25 YU YU01436/88A patent/YU143688A/xx unknown
- 1988-07-26 NO NO883299A patent/NO170284C/no not_active IP Right Cessation
- 1988-07-28 IT IT8821535A patent/IT1226825B/it active
- 1988-07-29 FR FR8810258A patent/FR2622193B1/fr not_active Expired - Lifetime
- 1988-07-29 NZ NZ225615A patent/NZ225615A/en unknown
- 1988-08-01 IL IL87290A patent/IL87290A/xx not_active IP Right Cessation
- 1988-08-01 FI FI883596A patent/FI87790C/fi not_active IP Right Cessation
- 1988-08-02 SK SK5412-88A patent/SK279325B6/sk unknown
- 1988-08-02 CZ CS19885412A patent/CZ286893B6/cs not_active IP Right Cessation
- 1988-08-03 NL NL8801934A patent/NL192683C/nl not_active IP Right Cessation
- 1988-08-03 PT PT88186A patent/PT88186B/pt not_active IP Right Cessation
- 1988-08-03 SE SE8802815A patent/SE502214C2/sv not_active IP Right Cessation
- 1988-08-03 ES ES8802434A patent/ES2010775A6/es not_active Expired
- 1988-08-03 DD DD88318652A patent/DD274423A5/de unknown
- 1988-08-03 GB GB8818462A patent/GB2207674B/en not_active Expired - Lifetime
- 1988-08-03 DD DD88326917A patent/DD299067A5/de unknown
- 1988-08-03 IE IE237888A patent/IE61040B1/en not_active IP Right Cessation
- 1988-08-03 KR KR1019880009910A patent/KR900006230B1/ko not_active IP Right Cessation
- 1988-08-03 DK DK434088A patent/DK169344B1/da not_active IP Right Cessation
- 1988-08-03 AT AT0195588A patent/AT398974B/de active
- 1988-08-03 HU HU884081A patent/HU202547B/hu unknown
- 1988-08-03 BE BE8800898A patent/BE1002982A4/fr not_active IP Right Cessation
- 1988-08-03 HU HU905862A patent/HU208147B/hu unknown
- 1988-08-03 JP JP63194307A patent/JPH0699465B2/ja not_active Expired - Lifetime
- 1988-08-04 DE DE3826562A patent/DE3826562A1/de active Granted
- 1988-08-04 CH CH2962/88A patent/CH676716A5/de not_active IP Right Cessation
- 1988-08-04 CA CA000573861A patent/CA1310637C/en not_active Expired - Lifetime
- 1988-08-04 GR GR880100512A patent/GR1000490B/el not_active IP Right Cessation
-
1989
- 1989-12-14 US US07/450,718 patent/US5041424A/en not_active Expired - Lifetime
-
1990
- 1990-01-19 YU YU00104/90A patent/YU10490A/xx unknown
- 1990-01-19 YU YU00103/90A patent/YU10390A/xx unknown
-
1991
- 1991-10-30 CN CN91108384A patent/CN1027169C/zh not_active Expired - Lifetime
- 1991-11-29 SG SG1012/91A patent/SG101291G/en unknown
-
1992
- 1992-01-16 HK HK63/92A patent/HK6392A/xx not_active IP Right Cessation
- 1992-01-22 NO NO920277A patent/NO920277D0/no unknown
- 1992-01-31 DK DK92119A patent/DK11992D0/da not_active Application Discontinuation
- 1992-02-20 NO NO920665A patent/NO172440C/no not_active IP Right Cessation
- 1992-06-12 MX MX9202851A patent/MX173843B/es unknown
- 1992-07-10 CY CY1625A patent/CY1625A/xx unknown
-
1994
- 1994-04-19 US US08/229,659 patent/USRE35524E/en not_active Expired - Lifetime
-
1995
- 1995-06-22 HU HU95P/P00387P patent/HU211960A9/hu unknown
-
1997
- 1997-09-24 LU LU90138C patent/LU90138I2/fr unknown
- 1997-12-05 NL NL970042C patent/NL970042I1/nl unknown
-
1998
- 1998-01-14 NO NO1998002C patent/NO1998002I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2010775A6 (es) | Procedimiento para la preparacion de derivados fosfatados de 4` -desmetilepipodofilotoxin glucosidos. | |
IL88363A0 (en) | Fluorocytidine derivatives,their production and pharmaceutical compositions containing them | |
NZ222527A (en) | N 9 -cyclopentyl-substituted adenosine derivatives and intermediate compound and pharmaceutical compositions | |
NZ220587A (en) | Milbemycin derivatives and compositions | |
NZ219577A (en) | Milbemycin derivatives and compositions | |
HK131993A (en) | Preparation of non-racemic furo(3,4-c)pyridine derivatives | |
EP0247819A3 (en) | Process for producing diadenosine tetraphosphate and derivatives thereof | |
ZA903859B (en) | Dimeric epipodophyllotoxin glucoside derivatives | |
IL86888A0 (en) | 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them | |
ZA883518B (en) | Nitrogen containing derivatives of epipodophyllotoxin glucosides | |
IL82896A0 (en) | 4(3h)-oxo-5,6,7,8-tetrahydropyrido(2,3-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
EP0305972A3 (en) | 3'- demethoxyepipodophyllotoxin glucoside derivatives | |
MY104067A (en) | Epipodophyllotoxin glucoside 4''-acyl derivatives | |
MY103552A (en) | Saccharide derivatives | |
IL87475A0 (en) | 4'-deshydroxyepipodophyllotoxin glucosides,their preparation and pharmaceutical compositions containing them | |
NZ223643A (en) | 23-deoxy-27-halo derivatives of ll-f28249 complex macrolides | |
NZ236106A (en) | 4'-demethylepipodophyllotoxin glucoside derivatives and pharmaceutical compositions | |
ZA885405B (en) | Epipodophyliotoxin glucoside 4'-phosphate derivatives | |
ZA905777B (en) | Asymmetric synthesis of furo(3,4-c)pyridine derivatives | |
AU610619C (en) | Epipodophyllotoxin glucose 4' - phosphate derivatives | |
GB8720380D0 (en) | Tc-99m-labelled monosaccharide derivatives | |
IE881999L (en) | Epipodophyllotoxin glucoside derivatives | |
SG125793G (en) | Preparation of non-racemic furo (3,4-c) pyridine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20080804 |